Evidence map›Paper›PMID 40619811›Full record

ArticleBriefings in bioinformatics2025

pMHChat, characterizing the interactions between major histocompatibility complex class II molecules and peptides with large language models and deep hypergraph learning.

Jiani Ma, Zhikang Wang, Cen Tong, Qi Yang, Lin Zhang, Hui Liu

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Article
  4. Artificial Intelligence Revolution in Transcriptomics: From Single Cells to Spatial Atlases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiani MaSchool of Information and Control Engineering, China University of Mining and Technology, No. 1 Daxue Road, Tongshan District, Xuzhou, Jiangsu 221116, China.ORCID 0000-0002-8126-0431
Zhikang WangDepartment of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Wellington Rd, Clayton, Melbourne, VIC 3800, Australia.ORCID 0000-0001-9587-1965
Cen TongWestern Crop Genetics Alliance, College of Science, Health, Engineering and Education, Murdoch University, South St, Murdoch, Perth, WA 6150, Australia.
Qi YangSchool of Information and Control Engineering, China University of Mining and Technology, No. 1 Daxue Road, Tongshan District, Xuzhou, Jiangsu 221116, China.
Lin ZhangSchool of Information and Control Engineering, China University of Mining and Technology, No. 1 Daxue Road, Tongshan District, Xuzhou, Jiangsu 221116, China.ORCID 0000-0002-7404-5231
Hui LiuSchool of Information and Control Engineering, China University of Mining and Technology, No. 1 Daxue Road, Tongshan District, Xuzhou, Jiangsu 221116, China.

Funding

China Postdoctoral Science Foundation 2024M763546
6 · The paper itself

Abstract

Characterizing the binding interactions between major histocompatibility complex (MHC) class II molecules and peptides is crucial for studying the immune system, offering potential applications for neoantigen design, vaccine development, and personalized immunotherapy. Motivated by this profound meaning, we developed a model that integrates large language models (LLMs) and deep hypergraph learning for predicting MHC class II-peptide binding reactivity, affinity, and residue contact profiling. pMHChat takes MHC pseudo-sequences and peptide sequences as inputs and processes them through four stages: LLMs fine-tune stage, feature encoding and map fusion stage, task-specific prediction stage, and downstream analysis stage. pMHChat distinguishes itself in capturing contextually relevant and high-order spatial interactions of the peptide-MHC (pMHC) complex. Specifically, in a five-fold cross-validation experiment, pMHChat achieves superior performance, with a mean area under the receiver operating characteristic curve of 0.8744 and an area under the precision-recall curve of 0.8390 in the binding reactivity task, as well as a mean Pearson correlation coefficient of 0.7311 in the binding affinity prediction task. Furthermore, pMHChat also demonstrates the best performance in both the leave-one-molecule-out setting and independent evaluation. Notably, pMHChat can provide residue contact profiling, showing its potential application in recognizing critical binding patterns of the pMHC complex. Our findings highlight pMHChat's capacity to advance both predictive accuracy and detailed insights into the MHC-peptide binding process. We anticipate that pMHChat will serve as a powerful tool for elucidating MHC-peptide interactions, with promising applications in immunological research and therapeutic development.

Indexed as

Computational BiologyDeep LearningHistocompatibility Antigens Class IIPeptidesHumansLarge Language ModelsProtein BindingHistocompatibility Antigens Class IIPeptideshypergraph convolutional networklarge language modelMHC class II-peptide bindingresidue contact profiling

Identifiers

PMID40619811
PMCPMC12229989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.